The sensitivity of melanoma cells to ferroptosis relies on their enhanced dependence on oxidative phosphorylation (OXPHOS), which is upregulated by BRAF inhibitors in BRAF-mutant melanoma cells, resulting in the accumulation of ROS [103, 104]. Here, BRAF is linked to melanoma.